News
Novartis is stopping the development of ianalumab in hidradenitis suppurativa (HS) after a Phase IIb proof-of-concept trial ...
As new treatments for systemic lupus erythematosus and lupus nephritis enter the armamentarium, revitalizing the management ...
5d
Bizcommunity on MSNLiving well with autoimmune disorders: Insights from MedshieldYour immune system is supposed to protect you from viruses, bacteria, and other harmful invaders. However, when you have an ...
A new study published in the Journal of American Medical Association showed that individuals with autoimmune skin diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results